Statement of Ownership (sc 13g)
February 16 2021 - 1:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Avanos Medical Inc.
|
(Name of Issuer)
|
Common Stock - $0.01 Par Value
|
|
(Title of Class of Securities)
|
08380V1Q6
|
|
(CUSIP Number)
|
|
December
31, 2020
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
x Rule
13d-1(b)
o Rule
13d-1(c)
o Rule
13d-1(d)
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. 08380V1Q6
|
SCHEDULE 13G
|
Page 2
of 8 Pages
|
|
|
|
|
|
1
|
NAME OF REPORTING PERSONS
Paradice Investment Management LLC
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
|
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
1,662,428
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
2,482,743
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,482,743
|
10
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
o
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
|
12
|
TYPE OF REPORTING PERSON
IA
|
CUSIP No. 08380V1Q6
|
SCHEDULE 13G
|
Page 3
of 8 Pages
|
|
|
|
|
|
1
|
NAME OF REPORTING PERSONS
Paradice Investment Management Pty Ltd
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
|
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Australia
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
1,662,428
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
2,482,743
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,482,743
|
10
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
o
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
|
12
|
TYPE
OF REPORTING PERSON
HC
|
CUSIP No. 08380V1Q6
|
SCHEDULE 13G
|
Page 4
of 8 Pages
|
Item 1.
|
|
(a) Name of Issuer
|
Avanos Medical Inc.
|
|
(b) Address of Issuer’s Principal
Executive Offices
|
5405
Windward Parkway Suite 100 South
Alpharetta, Georgia 30004
Item 2.
|
|
(a) Name of Person Filing
|
Paradice Investment Management LLC
Paradice Investment Management Pty Ltd
|
|
(b) Address
of Principal Business Office, or, if none, Residence
|
Paradice
Investment Management LLC
257
Fillmore Street, Suite 200
Denver, Colorado 80206
Paradice
Investment Management Pty Ltd
Level 27
The Chifley Tower
2 Chifley Square
Sydney NSW 2000
Australia
Paradice
Investment Management LLC - Delaware
Paradice
Investment Management Pty Ltd - Australia
|
|
(d) Title of Class of Securities
|
Common Stock - $0.01 Par Value
08380V1Q6
CUSIP No. 08380V1Q6
|
SCHEDULE 13G
|
Page 5
of 8 Pages
|
|
Item 3. If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
(a)
|
¨
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
|
|
(b)
|
¨
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
|
|
(c)
|
¨
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
|
|
(d)
|
¨
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
|
|
(e)
|
x
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
|
(f)
|
¨
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
(g)
|
x
|
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
|
(h)
|
¨
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
(i)
|
¨
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
|
(j)
|
¨
|
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
|
|
|
(k)
|
¨
|
A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
|
|
|
|
CUSIP
No. 08380V1Q6
|
SCHEDULE 13G
|
Page
6 of 8 Pages
|
Item
4. Ownership
The information as of the filing date required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for
each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
Item
5. Ownership of Five Percent or Less of a Class
Not Applicable.
Item
6. Ownership of More Than Five Percent on Behalf of Another Person
Not Applicable.
Item
7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent
Holding Company or Control Person
Not Applicable.
Item
8. Identification and Classification of Members of the Group
Not Applicable.
Item
9. Notice of Dissolution of Group
Not Applicable.
Item
10. Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and
are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with
or as a participant in any transaction having that purpose or effect.
CUSIP No. 08380V1Q6
|
SCHEDULE 13G
|
Page 7
of 8 Pages
|
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 16, 2021
|
Paradice Investment Management LLC
|
|
|
|
|
|
By:
|
Lucinda Hill
|
|
|
Name:
|
Lucinda Hill
|
|
|
Title:
|
Chief Compliance Officer
|
|
Paradice Investment Management Pty Ltd
|
|
|
|
|
|
|
|
By:
|
Peter Manley
|
|
|
Name:
|
Peter Manley
|
|
|
Title:
|
Chief Operating Officer
|
|
CUSIP No. 08380V1Q6
|
SCHEDULE 13G
|
Page 8
of 8 Pages
|
JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned hereby agree that the
Statement on this Schedule 13G, dated February 16, 2021, (the "Schedule 13G"), with respect to the Common Stock - $0.01 Par Value
of Avanos Medical Inc. is filed, and all amendments thereto will be filed, on behalf of each of us pursuant to and in
accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this
Agreement shall be included as an Exhibit to the Schedule 13G. Each of the undersigned agrees to be responsible for the
timely filing of the Schedule 13G, and for the completeness and accuracy of the information concerning itself contained
therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and
the same instrument.
IN WITNESS WHEREOF, the undersigned have
executed this Agreement as of the 16th day of February 2021.
|
Paradice Investment Management LLC
|
|
|
|
|
|
By:
|
Lucinda Hill
|
|
|
Name:
|
Lucinda Hill
|
|
|
Title:
|
Chief Compliance Officer
|
|
Paradice Investment Management Pty Ltd
|
|
|
|
|
|
|
|
By:
|
Peter Manley
|
|
|
Name:
|
Peter Manley
|
|
|
Title:
|
Chief Operating Officer
|
Avanos Medical (NYSE:AVNS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Avanos Medical (NYSE:AVNS)
Historical Stock Chart
From Aug 2023 to Aug 2024